Gynecologic infections

Emergency Medicine Clinics of North America

Volumn 21, Issue 3, 2003, Pages 631-648

  Zeger, Wesley ^a,b   Holt, Kurtis ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; ANTIFUNGAL AGENT; AZITHROMYCIN; CEFIXIME; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CLINDAMYCIN; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; ESTROGEN; FAMCICLOVIR; FLUCONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; ORAL CONTRACEPTIVE AGENT; PAROMOMYCIN; PENICILLIN G; PYRROLE DERIVATIVE; SPECTINOMYCIN; SULTAMICILLIN; TINIDAZOLE; ZINC SULFATE;

ABSCESS; BARTHOLIN GLAND; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG CHOICE; FITZ HUGH CURTIS SYNDROME; GENITAL HERPES; GYNECOLOGIC INFECTION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HUMAN; NEISSERIA GONORRHOEAE; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYPHILIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; TUBOOVARIAN ABSCESS; UTERINE CERVICITIS; VAGINA CANDIDIASIS; VAGINITIS; VIRUS TRANSMISSION;

EID: 0042859893     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8627(03)00039-7     Document Type: Article

References (74)

1. American College of Obstetricians and Gynecologists practice bulletin. Management of herpes in pregnancy. Number 8, October 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000;68:165-73.
2. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002;51:1-78.
3. Summary of notifiable diseases, United States, 1997. MMWR Morb Mortal Wkly Rep 1002;46: ii-vii, 3-87.
4. Ashley RL, Corey L. HSV type specific antibody tests: patients are ready, are clinicians? Genitourin Med 1997;73:235-6.
5. Barton SE. Herpes management and prophylaxis. Dermatol Clin 1998;16:799-803.
6. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847-54.
7. Blanchard AC, Pastorek II JG, Weeks T. Pelvic inflammatory disease during pregnancy. South Med J 1987;80:1363-5.
8. Blumstein H. Incision and drainage. In: Roberts J, Hedges JR, editors. Clinical procedures in emergency medicine. 3rd edition. Philadelphia: WB Saunders; 1998. p. 646-7.
9. Brown ZA. Genital herpes complicating pregnancy. Dermatol Clin 1998;16:xiv, 805-10.
10. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
11. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534-40.
12. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47:1-111.
13. Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance, 1997. Atlanta: US Department of Health and Human Services; 1998. p. 143.
14. Cohen F, Kemeny ME, Kearney KA, et al. Persistent stress as a predictor of genital herpes recurrence. Arch Intern Med 1999;159:2430-6.
15. Corey L. Raising the consciousness for identifying and controlling viral STDs: fears and frustrations-Thomas Parran Award Lecture. Sex Transm Dis 1998;25:58-69.
16. Counselman FL. An unusual presentation of Fitz-Hugh-Curtis syndrome. J Emerg Med 1994;12:167-70.
17. Sutton MY. Lower genital tract infections and HIV in women. Curr Infect Dis Rep 2000;2:539-45.
18. Diamond C, Selke S, Ashley R, et al. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm Dis 1999;26:221-5.
19. Drake S, Taylor S, Brown D, et al. Improving the care of patients with genital herpes. BMJ 2000;321:619-23.
20. Emmert DH, Kirchner JT. Sexually transmitted diseases in women. Gonorrhea and syphilis. Postgrad Med 2000;107:181-4, 189-90, 193-7.
21. Ferris DG, Litaker MS, Woodward L, et al. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995;41:443-9.
22. Fiorino AS. Intrauterine contraceptive device-associated actinomycotic abscess and Actinomyces detection on cervical smear. Obstet Gynecol 1996;87:142-9.
23. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
24. Frenkel LM, Garratty EM, Shen JP, et al. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993;118:414-8.
25. Gareen IF, Greenland S, Morgenstern H. Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990. Epidemiology 2000;11:589-97.
26. Gatt D, Heafield T, Jantet G. Curtis-Fitz-Hugh syndrome: the new mimicking disease? Ann R Coll Surg Engl 1986;68:271-4.
27. Gatt D, Jantet G. Perisplenitis and perinephritis in the Curtis-Fitz-Hugh syndrome. Br J Surg 1987;74:110-2.
28. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013-9.
29. Hemsel DL, Ledger WJ, Martens M, et al. Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease. Clin Infect Dis 2001;32:103-7.
30. Hill DA, Lense JJ. Office management of Bartholin gland cysts and abscesses. Am Fam Physician 1998;57:1611-6, 1619-20.
31. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-42.
32. Hoffman L, Ma OJ, Gaddis G, et al. Cervical infections in emergency department patients with vaginal bleeding. Acad Emerg Med 2002;9:781-5.
33. Hunt SM, Kincheloe BW, Schreier PC. Tubo-ovarian abscess in pregnancy. Obstet Gynecol 1974;43:57-60.
34. Kirchner JT, Emmert DH. Sexually transmitted diseases in women. Chlamydia trachomatis and herpes simplex infections. Postgrad Med 2000;107:55-8, 61-5.
35. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
36. Korn AP. Gynecologic care of women infected with HIV. Clin Obstet Gynecol 2001;44:226-42.
37. Koumans EH, Kendrick JS. Preventing adverse sequelae of bacterial vaginosis: public health program and research agenda. CDC Bacterial Vaginosis Working Group. Sex Transm Dis 2001;28:292-7.
38. Larkin JA, Lit L, Toney J, et al. Recognizing and treating syphilis in pregnancy. Medscape Womens Health 1998;3:5.
39. Lepine LA, Hillis SD, Marchbanks PA, et al. Severity of pelvic inflammatory disease as a predictor of the probability of live birth. Am J Obstet Gynecol 1998;178:977-81.
40. Lopez-Zeno JA, Keith LG, Berger GS. The Fitz-Hugh-Curtis syndrome revisited. Changing perspectives after half a century. J Reprod Med 1985;30:567-82.
41. McCormick M, DelCastillo J, Berk RS. An atypical presentation of the Fitz-Hugh-Curtis syndrome. J Emerg Med 1990;8:55-8.
42. McGee D. Miscellaneous urologic conditions. In: Harwood-Nuss A, Wolfson A, Linden C, et al, editors. The clinical practice of emergency medicine. 3rd edition. Philadelphia: Lippincott Williams & Wilkins; 2001, p. 312.
43. McGregor JA, French JI. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000;55:S1-19.
44. Mertz GJ, Schmidt O, Jourden JL, et al. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985;12:33-9.
45. Mole L, Ripich S, Margolis D, et al. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176:766-70.
46. Morris M, Nicoll A, Simms I, et al. Bacterial vaginosis: a public health review. BJOG 2001;108:439-50.
47. Murthy JH, Hiremagalur SR. Differentiation of tubo-ovarian abscess from pelvic inflammatory disease, and recent trends in the management of tubo-ovarian abscess. J Tenn Med Assoc 1995;88:136-8.
48. Ness RB, Soper DE, Peipert J, et al. Design of the PID Evaluation and Clinical Health (PEACH) Study. Control Clin Trials 1998;19:499-514.
49. Oleszczuk LJ, Keith LG. Vaginal infection: prophylaxis and perinatal outcome-a review of the literature. Int J Fertil Womens Med 2000;45:358-67.
50. Oxman MN. Genital herpes. In: Gorbach SL, BJBN editor. Infectious diseases. 2nd edition. Philadelphia: WB Saunders; 1998, p. 986-1007.
51. Pavletic AJ, Wolner-Hanssen P, Paavonen J, et al. Infertility following pelvic inflammatory disease. Infect Dis Obstet Gynecol 1999;7:145-52.
52. Peipert JF, Ness RB, Soper DE, et al. Association of lower genital tract inflammation with objective evidence of endometritis. Infect Dis Obstet Gynecol 2000;8:83-7.
53. Prober CG. Herpetic vaginitis in 1993. Clin Obstet Gynecol 1993;36:177-87.
54. Rachinsky I, Boguslavsky L, Goldstein D, et al. Diagnosis of pyogenic pelvic inflammatory diseases by 99mTc-HMPAO leukocyte scintigraphy. Eur J Nucl Med 2000;27:1774-7.
55. Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ 1999;319:220-3.
56. Reljic M, Gorisek B. C-reactive protein and the treatment of pelvic inflammatory disease. Int J Gynaecol Obstet 1998;60:143-50.
57. Rodgers CA, O'Mahony C. High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex. Int J STD AIDS 1995;6:144.
58. Rome ES. Pelvic inflammatory disease: the importance of aggressive treatment in adolescents. Cleve Clin J Med 1998;65:369-76.
59. Ross J. Pelvic inflammatory disease. BMJ 2001;322:658-9.
60. Sanford J. Sanford guide to antimicrobial therapy. 32nd edition. Hyde Park (VT): Antimicrobial Therapy Inc; 2002.
61. Schwebke JR. Bacterial vaginosis. Curr Infect Dis Rep 2000;2:14-7.
62. Shanahan D, Lord PH, Grogono J, et al. Clinical acute cholecystitis and the Curtis-Fitz-Hugh syndrome. Ann R Coll Surg Engl 1988;70:44-6.
63. Sherer DM, Schwartz BM, Abulafia O. Management of pelvic abscess during pregnancy: a case and review of the literature. Obstet Gynecol Surv 1999;54:655-62.
64. Slap GB, Forke CM, Cnaan A, et al. Recognition of tubo-ovarian abscess in adolescents with pelvic inflammatory disease. J Adolesc Health 1996;18:397-403.
65. Sobel JD. Vaginitis. N Engl J Med 1997;337:1896-903.
66. Stephenson J. New therapy promising for genital herpes. JAMA 2001;285:2182-3.
67. Sweet RL. Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol 2000;8:184-90.
68. Derchi LE, Serafini G, Gandolfo N, et al. Ultrasound in gynecology. Eur Radiol 2001;11:2137-55.
69. van Der Schee C, van Belkum A, Zwijgers L, et al. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J Clin Microbiol 1999;37:4127-30.
70. 701 van Dongen PW. Diagnosis of Fitz- Hugh-Curtis syndrome by ultrasound. Eur J Obstet Gynecol Reprod Biol 1993;50:159-62.
71. Wald A. Herpes. Transmission and viral shedding. Dermatol Clin 1998;16(xiv):795-7.
72. Walker CK, Workowski KA, Washington AE, et al. Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases. Clin Infect Dis 1999;28(Suppl 1):S29-36.
73. Xu F, Schillinger JA, Aubin MR, et al. Sexually transmitted diseases of older persons in Washington State. Sex Transm Dis 2001;28:287-91.
74. Yealy DM, Greene TJ, Hobbs GD. Underrecognition of cervical Neisseria gonorrhoeae and Chlamydia trachomatis infections in the emergency department. Acad Emerg Med 1997;4:962-7.